TIE2 Associates with Caveolae and Regulates Caveolin-1 To Promote Their Nuclear Translocation

REFERENCES

• Martin V, Liu D, Fueyo J, Gomez-Manzano C. 2008. Tie2: a journey from normal angiogenesis to cancer and beyond. Histol Histopathol 23:773–780. https://doi.org/10.14670/HH-23.773.
   PubMed Web of Science ®Google Scholar
• Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407:242–248. https://doi.org/10.1038/35025215.
   PubMed Web of Science ®Google Scholar
• Hossain MB, Shifat R, Johnson DG, Bedford MT, Gabrusiewicz KR, Cortes-Santiago N, Luo X, Lu Z, Ezhilarasan R, Sulman EP, Jiang H, Li SS, Lang FF, Tyler J, Hung MC, Fueyo J, Gomez-Manzano C. 2016. TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1. Sci Adv 2:e1501290. https://doi.org/10.1126/sciadv.1501290.
   PubMed Web of Science ®Google Scholar
• Lee OH, Xu J, Fueyo J, Fuller GN, Aldape KD, Alonso MM, Piao Y, Liu TJ, Lang FF, Bekele BN, Gomez-Manzano C. 2006. Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix. Mol Cancer Res 4:915–926. https://doi.org/10.1158/1541-7786.MCR-06-0184.
   PubMed Web of Science ®Google Scholar
• Liu D, Martin V, Fueyo J, Lee OH, Xu J, Cortes-Santiago N, Alonso MM, Aldape K, Colman H, Gomez-Manzano C. 2010. Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotype. Oncotarget 1:700–709. https://doi.org/10.18632/oncotarget.204.
   PubMed Web of Science ®Google Scholar
• Goh LK, Sorkin A. 2013. Endocytosis of receptor tyrosine kinases. Cold Spring Harb Perspect Biol 5:a017459. https://doi.org/10.14670/HH-23.773.
   PubMed Web of Science ®Google Scholar
• Sorkin A, von Zastrow M. 2009. Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 10:609–622. https://doi.org/10.1038/nrm2748.
   PubMed Web of Science ®Google Scholar
• Chen MK, Hung MC. 2015. Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases. FEBS J 282:3693–3721. https://doi.org/10.1111/febs.13342.
   PubMed Web of Science ®Google Scholar
• Chou RH, Wang YN, Hsieh YH, Li LY, Xia W, Chang WC, Chang LC, Cheng CC, Lai CC, Hsu JL, Chang WJ, Chiang SY, Lee HJ, Liao HW, Chuang PH, Chen HY, Wang HL, Kuo SC, Chen CH, Yu YL, Hung MC. 2014. EGFR modulates DNA synthesis and repair through Tyr phosphorylation of histone H4. Dev Cell 30:224–237. https://doi.org/10.1016/j.devcel.2014.06.008.
   PubMed Web of Science ®Google Scholar
• Conner SD, Schmid SL. 2003. Regulated portals of entry into the cell. Nature 422:37–44. https://doi.org/10.1038/nature01451.
   PubMed Web of Science ®Google Scholar
• Doherty GJ, McMahon HT. 2009. Mechanisms of endocytosis. Annu Rev Biochem 78:857–902. https://doi.org/10.1146/annurev.biochem.78.081307.110540.
   PubMed Web of Science ®Google Scholar
• Tomas A, Futter CE, Eden ER. 2014. EGF receptor trafficking: consequences for signaling and cancer. Trends Cell Biol 24:26–34. https://doi.org/10.1016/j.tcb.2013.11.002.
   PubMed Web of Science ®Google Scholar
• Delos Santos RC, Garay C, Antonescu CN. 2015. Charming neighborhoods on the cell surface: plasma membrane microdomains regulate receptor tyrosine kinase signaling. Cell Signal 27:1963–1976. https://doi.org/10.1016/j.cellsig.2015.07.004.
   PubMed Web of Science ®Google Scholar
• Parton RG, del Pozo MA. 2013. Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol 14:98–112. https://doi.org/10.1038/nrm3512.
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Sotgia F, Lisanti MP. 2015. Caveolae and signalling in cancer. Nat Rev Cancer 15:225–237. https://doi.org/10.1038/nrc3915.
   PubMed Web of Science ®Google Scholar
• Khan EM, Heidinger JM, Levy M, Lisanti MP, Ravid T, Goldkorn T. 2006. Epidermal growth factor receptor exposed to oxidative stress undergoes Src- and caveolin-1-dependent perinuclear trafficking. J Biol Chem 281:14486–14493. https://doi.org/10.1074/jbc.M509332200.
   PubMed Web of Science ®Google Scholar
• Labrecque L, Royal I, Surprenant DS, Patterson C, Gingras D, Beliveau R. 2003. Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol Biol Cell 14:334–347. https://doi.org/10.1091/mbc.E02-07-0379.
   PubMed Web of Science ®Google Scholar
• Bogdanovic E, Coombs N, Dumont DJ. 2009. Oligomerized Tie2 localizes to clathrin-coated pits in response to angiopoietin-1. Histochem Cell Biol 132:225–237. https://doi.org/10.1007/s00418-009-0603-3.
   PubMedGoogle Scholar
• Bogdanovic E, Nguyen VP, Dumont DJ. 2006. Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization. J Cell Sci 119:3551–3560. https://doi.org/10.1242/jcs.03077.
   PubMed Web of Science ®Google Scholar
• Torgersen ML, Skretting G, van Deurs B, Sandvig K. 2001. Internalization of cholera toxin by different endocytic mechanisms. J Cell Sci 114:3737–3747.
   PubMed Web of Science ®Google Scholar
• Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. 1997. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 272:6525–6533.
   PubMed Web of Science ®Google Scholar
• Hill MM, Bastiani M, Luetterforst R, Kirkham M, Kirkham A, Nixon SJ, Walser P, Abankwa D, Oorschot VM, Martin S, Hancock JF, Parton RG. 2008. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 132:113–124. https://doi.org/10.1016/j.cell.2007.11.042.
   PubMed Web of Science ®Google Scholar
• Fridolfsson HN, Roth DM, Insel PA, Patel HH. 2014. Regulation of intracellular signaling and function by caveolin. FASEB J 28:3823–3831. https://doi.org/10.1096/fj.14-252320.
   PubMedGoogle Scholar
• Lee HH, Wang YN, Hung MC. 2015. Non-canonical signaling mode of the epidermal growth factor receptor family. Am J Cancer Res 5:2944–2958.
   PubMedGoogle Scholar
• Zimnicka AM, Husain YS, Shajahan AN, Sverdlov M, Chaga O, Chen Z, Toth PT, Klomp J, Karginov AV, Tiruppathi C, Malik AB, Minshall RD. 2016. Src-dependent phosphorylation of caveolin-1 Tyr-14 promotes swelling and release of caveolae. Mol Biol Cell 27:2090–2106. https://doi.org/10.1091/mbc.E15-11-0756.
   PubMed Web of Science ®Google Scholar
• Abulrob A, Giuseppin S, Andrade MF, McDermid A, Moreno M, Stanimirovic D. 2004. Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae. Oncogene 23:6967–6979. https://doi.org/10.1038/sj.onc.1207911.
   PubMed Web of Science ®Google Scholar
• Feng Y, Venema VJ, Venema RC, Tsai N, Caldwell RB. 1999. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun 256:192–197. https://doi.org/10.1006/bbrc.1998.9790.
   PubMed Web of Science ®Google Scholar
• Dittmann K, Mayer C, Kehlbach R, Rodemann HP. 2008. Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Mol Cancer 7:69. https://doi.org/10.1186/1476-4598-7-69.
   PubMed Web of Science ®Google Scholar
• Chen Z, Bakhshi FR, Shajahan AN, Sharma T, Mao M, Trane A, Bernatchez P, van Nieuw Amerongen GP, Bonini MG, Skidgel RA, Malik AB, Minshall RD. 2012. Nitric oxide-dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS/caveolin-1 binding and eNOS inhibition. Mol Biol Cell 23:1388–1398. https://doi.org/10.1091/mbc.E11-09-0811.
   PubMed Web of Science ®Google Scholar
• Parat MO, Riggins GJ. 2012. Caveolin-1, caveolae, and glioblastoma. Neuro Oncol 14:679–688. https://doi.org/10.1093/neuonc/nos079.
   PubMed Web of Science ®Google Scholar
• Sanna E, Miotti S, Mazzi M, De Santis G, Canevari S, Tomassetti A. 2007. Binding of nuclear caveolin-1 to promoter elements of growth-associated genes in ovarian carcinoma cells. Exp Cell Res 313:1307–1317. https://doi.org/10.1016/j.yexcr.2007.02.005.
   PubMed Web of Science ®Google Scholar
• Mahmood J, Zaveri SR, Murti SC, Alexander AA, Connors CQ, Shukla HD, Vujaskovic Z. 2016. Caveolin-1: a novel prognostic biomarker of radioresistance in cancer. Int J Radiat Biol 92:747–753. https://doi.org/10.1080/09553002.2016.1222096.
   PubMed Web of Science ®Google Scholar
• Zhu H, Yue J, Pan Z, Wu H, Cheng Y, Lu H, Ren X, Yao M, Shen Z, Yang JM. 2010. Involvement of Caveolin-1 in repair of DNA damage through both homologous recombination and non-homologous end joining. PLoS One 5:e12055. https://doi.org/10.1371/journal.pone.0012055.
   Google Scholar
• Jiang H, Gomez-Manzano C, Aoki H, Alonso MM, Kondo S, McCormick F, Xu J, Kondo Y, Bekele BN, Colman H, Lang FF, Fueyo J. 2007. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst 99:1410–1414. https://doi.org/10.1093/jnci/djm102.
   PubMed Web of Science ®Google Scholar
• Gourzoulidou E, Carpintero M, Baumhof P, Giannis A, Waldmann H. 2005. Inhibition of angiogenesis-relevant receptor tyrosine kinases by sulindac analogues. Chembiochem 6:527–531. https://doi.org/10.1002/cbic.200400192.
   PubMedGoogle Scholar
• Lu Z, Ghosh S, Wang Z, Hunter T. 2003. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 4:499–515. https://doi.org/10.1016/S1535-6108(03)00304-0.
   PubMed Web of Science ®Google Scholar
• Audero E, Cascone I, Maniero F, Napione L, Arese M, Lanfrancone L, Bussolino F. 2004. Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells. J Biol Chem 279:13224–13233. https://doi.org/10.1074/jbc.M307456200.
   PubMed Web of Science ®Google Scholar
• Seegar TC, Eller B, Tzvetkova-Robev D, Kolev MV, Henderson SC, Nikolov DB, Barton WA. 2010. Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands. Mol Cell 37:643–655. https://doi.org/10.1016/j.molcel.2010.02.007.
   PubMed Web of Science ®Google Scholar